Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseasesUlrike Billmeier, Raja Atreya|World Journal of Gastroenterology|2016Cited by 211
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational studyLaurent Goessens, Eugeni Domènech, Anneline Cremer et al.|United European Gastroenterology Journal|2021Cited by 71
Metabolic stress sensing by epithelial RXRα links westernization of diet with Crohn’s diseaseMoritz Meyer, Timon E. Adolph, Felix Grabherr et al.|Cell Metabolism|2025Cited by 2
130 Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)Bruce E. Sands, Séverine Vermeire, Silvio Danese et al.|The American Journal of Gastroenterology|2025Cited by 1
Erratum: Corrigendum: Transcriptional programs of the lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homingPatricia R. Taylor, Eugene C. Butcher, Sanhita Roy et al.|Nature Immunology|2015Cited by 0